%0 Journal Article %T HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer %A Yamaoka, Toshimitsu %A Tsurutani, Junji %A Sagara, Hironori %A Ohmori, Tohru %J Translational Lung Cancer Research %D 2020 %B 2020 %9 %! HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer %K %X %U https://tlcr.amegroups.org/article/view/41089 %V 9 %N 5 %P 2178-2183 %@ 2226-4477